What a Patient Is Actually Asking: New Sterile Cartridge versus Reused Needles
Before an in-clinic mechanical microneedling or radiofrequency (RF) microneedling session, the practical question is: how can you tell whether the needle cartridge or tip that will puncture skin is a new sterile pack for this visit, and what does it mean if staff say they cleaned, autoclaved, or saved it?
On FDA-cleared powered microneedle devices (product code QAI), the Agency’s classification record describes the physical state as a powered pen with a single-use needle cartridge and a multi-use motorized base. The labeled technical method punctures skin to pinpoint bleeding. That split—disposable patient-contacting cartridge versus reusable motorized base—is the hygiene boundary this page maps. It is not a claim that a particular office followed the labeled workflow, and it is not the same question as the October 2025 RF energy-injury warning (burns, scarring, fat loss, disfigurement, and nerve damage from heat and depth).
Named clearance summaries make the same split explicit. SkinPen’s De Novo and later 510(k) describe a sterile, disposable cartridge “not to be resterilized or reused,” with a separate nonsterile disposable BioSheath over the reusable handpiece. Exceed’s 510(k) states that the safety needle cartridge “is sterile and for single use only.” Vivace’s 510(k) states each disposable micro-needle cartridge “is supplied sterile and is for single patient use only and cannot be re-sterilized,” while the generator and handpiece are not disposable. InMode’s Morpheus8/RF Pro summaries describe gamma-sterilized fractional tips that are for single use, with the handle reprocessed per the user manual.
If staff say a used cartridge was “sanitized,” wiped with alcohol or hypochlorous acid, autoclaved, or stored for your next appointment, that is not the labeled workflow in those summaries. It is also not the same thing as FDA-regulated reprocessing of a single-use device, which treats a hospital or third-party reprocessor as a manufacturer and requires specific labeling. Under OSHA’s bloodborne-pathogens standard, a needle that has contacted blood is a contaminated sharp: it is not recapped for reuse and is discarded in a sharps container as soon as feasible. A practical check is visual and verbal only: a sealed, in-date pack opened for that session, a device name that matches what you booked, and the used cartridge going into a sharps container—not back into a drawer.
How the FDA Splits the Device: QAI Pens, GEI RF Tips, and Products That Are Not Devices
Mechanical powered pens and RF pin platforms are not one classification, even when both leave a grid of punctures. Mixing those pathways is how “we sterilized the tip” and “FDA-cleared device” get treated as interchangeable.
Motorized mechanical pens sit under 21 CFR 878.4430 as Class II devices, product code QAI. The identification is a device that uses one or more needles to mechanically puncture and injure skin tissue for aesthetic use. The same section excludes devices intended for transdermal delivery of topical products such as cosmetics, drugs, or biologics. FDA’s product-classification page states the physical state as a powered microneedle pen with a single-use needle cartridge and a multi-use motorized base, and the technical method as mechanical puncture to pinpoint bleeding. Because the needles are intended to reach living, vascularized tissue, bloodborne-pathogen rules for contaminated sharps apply to the cartridge after use.
RF microneedling platforms in the Vivace and InMode/Morpheus8 summaries are classified under 21 CFR 878.4400 as electrosurgical cutting and coagulation devices and accessories (product code GEI). Those 510(k)s still treat the patient-contacting pin array as a sterile, single-use accessory and the generator or handle as the reprocessed part. That is a hygiene parallel, not proof that 21 CFR 878.4430 special controls automatically apply to RF tips, and not proof that every historical RF pin was supplied sterile. K192695’s comparison table records an older Fractora configuration that was non-sterile and to be sterilized before use, versus current Morpheus8 applicator tip heads that are gamma sterilized and for single use. For how mechanical needling and RF energy differ clinically, see microneedling versus RF microneedling; for platform-level RF comparisons, see Morpheus8, Sylfirm X, and Profound.
FDA’s consumer update (content current as of 15 October 2025) draws a third line: not every roller sold as “microneedling” is a medical device. Products with short or blunt needles that do not penetrate living skin and that claim only exfoliation or appearance improvement may fall outside the medical-device definition and are more commonly sold for home use. FDA has not authorized any microneedling medical device for over-the-counter sale. Consumer cleaning instructions on a cosmetic roller are not a protocol for a prescription QAI or GEI system that is intended to reach pinpoint bleeding.
The same consumer update states that FDA has not cleared microneedling devices for use with another product such as platelet-rich plasma (PRP), drugs, or cosmetics, and that RF microneedling devices work by a different energy mechanism and carry different risks. Stamping PRP, exosomes, or a serum into open punctures is therefore outside the cleared mechanical-device identification in 878.4430. That combination question is covered separately in PRP versus microneedling and the vampire-facial infection-control record.
What “Sterile Single-Use” Means in Special Controls and 510(k) Language
Class II clearance for a QAI aesthetic microneedling device is contingent on the special controls in 21 CFR 878.4430. Those controls do not themselves use the word “cartridge,” but they locate sterility, packaging, and reprocessing on specific parts of the system:
Performance data must demonstrate sterility of the patient-contacting components of the device (878.4430(b)(3)).
Shelf-life data must show continued sterility, package integrity, and device functionality over the intended shelf life (b)(4)).
Nonclinical performance must include safety features against cross-contamination, including fluid ingress protection (b)(2)(ii)).
Cleaning and disinfection instructions must be validated for reusable components (b)(8)), and labeling must include those reprocessing methods, disposal instructions, and a shelf life (b)(9).
That list is a manufacturer obligation for the cleared system. It is not a clinic license to reuse the needles. Validated reprocessing in the special controls is aimed at reusable components. Disposal instructions and single-use cartridge language in the 510(k)s sit on the patient-contacting pack.
Where summaries name a sterility assurance level, they do so as part of the submission, not as a number printed in 878.4430. SkinPen’s De Novo (DEN160029) states the needle cartridge is ethylene-oxide sterilized with a sterility assurance level (SAL) of 10^-6, validated to ISO 11135-1. Vivace’s K193070 likewise reports cartridge sterility to SAL 10^-6 with ISO 11135 ethylene-oxide standards. SAL 10^-6 means the validated process is designed so the chance of a viable microorganism remaining on the sterilized item is no more than one in a million. That is industrial terminal sterilization of a sealed pack—not a benchtop autoclave cycle on a used cartridge.
Public summaries for the four systems used as examples:
| Platform | FDA identifier | Patient-contacting part | Reusable part / barrier |
|---|---|---|---|
| SkinPen Precision | DEN160029 / K202243 (QAI, 21 CFR 878.4430) | Sterile, disposable needle cartridge; EO to SAL 10^-6; labeled not to be resterilized or reused. DEN160029 also describes a lock-out that prevents installing a used cartridge a second time. | Reusable handpiece, supplied non-sterile; nonsterile disposable BioSheath cover; reprocessing tests on the sheath barrier and handpiece. |
| Exceed | K182407 (QAI) | Safety needle cartridge “is sterile and for single use only”; screwed into the handpiece; adjustable protrusion 0.0–1.5 mm. | Reusable handpiece; the 510(k) lists a handpiece cover among system components. The summary does not describe cartridge reuse or a named wipe brand. |
| Vivace | K193070 (GEI, 21 CFR 878.4400) | Each disposable micro-needle cartridge “is supplied sterile and is for single patient use only and cannot be re-sterilized”; SAL 10^-6, ISO 11135 EO. | RF generator and handpiece “are not disposable.” |
| Morpheus8 / InMode RF Pro | K192695 / K210492 (GEI) | Disposable, single-use fractional RF pin tip; “All tips are Gamma-sterilized”; ISO 11137-1 in K192695. K192695 also notes an older Fractora predicate tip that was non-sterile and to be sterilized before use. | “Handle to be reprocessed in accordance with user manual instructions. Tips are for single-use.” |
A recurring confusion is systems marketed with an autoclaveable metal housing or nosecone. That architecture, when it exists, is about the reusable shell. It does not convert the patient-contacting needle array into a reprocessable instrument. SkinPen’s summaries locate the autoclave-incompatible motor in the pen body and put hygiene on a disposable BioSheath plus a sealed cartridge with fluid-ingress protection. For how SkinPen, Exceed, and SkinStylus split sheath versus housing workflows without answering the patient reuse checklist, see FDA-cleared powered microneedling devices: SkinPen vs Exceed vs SkinStylus. This page does not rest on a SkinStylus 510(k) text.
Two other boundaries belong in the same table’s footnotes. First, “single patient use” in Vivace’s wording is still one procedure: FDA’s SUD definition (below) is one use, or one patient during a single procedure, not storage of a used tip for that person’s next visit. Second, duration-of-sharpness marketing is not a sterility or reuse clearance. A cartridge remaining sharp through a long treatment window, if a manufacturer claims it, does not authorize wiping and saving the same needles.
If a Clinic Says the Cartridge Was Cleaned or Autoclaved
FDA’s page on reprocessing single-use medical devices (current as of 1 August 2024) defines a single-use device as intended for one use, or on a single patient during a single procedure. An original manufacturer may label a device for single use because it was not designed or tested for reuse. The Agency also states that the absence of OEM reuse testing does not, by itself, mean no SUD can ever be reprocessed. Hospitals and third-party reprocessors that do reprocess SUDs are regulated like original manufacturers and generally must show the reprocessed device remains as safe and effective, including a 510(k) with validation data for Class I/II SUDs unless an exemption applies.
Federal labeling for a legitimately reprocessed SUD must include: “Reprocessed device for single use. Reprocessed by [the person or establishment responsible for reprocessing].” Devices that lack that statement are considered misbranded. That pathway is a registered manufacturer activity with validation and labeling. It is not a med-spa alcohol wipe, HOCl spray, or benchtop autoclave cycle on a cartridge whose 510(k) says do not resterilize.
The public 510(k) and De Novo summaries cited here do not identify a cleared third-party reprocessed aesthetic microneedling cartridge or a Morpheus8/Vivace-style RF tip. That is not a completed search of every SUD 510(k). It is a reason to treat authorized reprocessing of these specific tips as theoretical until a labeled, validated reprocessed device exists—not as current clinic practice. Wiping a used cartridge is not participating in that federal program.
OSHA 29 CFR 1910.1030 is an employer duty to workers, not a patient bill of rights, but it shapes what should happen to a blood-contaminated cartridge. Universal precautions treat blood as potentially infectious for HIV, HBV, and other bloodborne pathogens. Contaminated needles and other contaminated sharps shall not be bent, recapped, or removed except narrow demonstrated exceptions; shearing or breaking of contaminated needles is prohibited. Contaminated sharps must be discarded immediately or as soon as feasible in closable, puncture-resistant, labeled or color-coded containers located as close as feasible to the point of use. Storing a used cartridge in a named envelope or drawer is not that workflow.
CDC’s injection-safety page allows, in limited settings, reuse of the same syringe and needle on the same patient during a single procedure when incremental dosing is integral and the syringe is never left unattended. That exception does not authorize storing a used microneedling cartridge for a later visit, using it on another person, or treating an RF tip as a multi-session rental. CDC’s single-dose-vial rule is the closer analogue: a single-dose container is for a single patient and a single case, procedure, or injection and should not be retained for later use even on the same patient.
Surface disinfectants used on counters, handles, or a BioSheath-covered pen body are a different job from sterilization of a used sharp. Hypochlorous acid can have a role in clinic surface cleaning; it does not replace a factory-sterile cartridge. That distinction is developed in HOCl disinfectant use in aesthetic clinics. Practice-owner pressure to reuse tips is an economics problem, not a sterility clearance; see med-spa consumable unit economics.
flowchart TD
A[Reusable handpiece or console] -->|Between patients| B[Labeled cleaning or disinfection]
B --> A
C[Barrier sheath if the IFU uses one] -->|Each session| D[Cover the handle]
D --> E[Discard the sheath]
F[Sealed sterile cartridge or RF tip] -->|Open for this visit| G[Attach and treat]
G --> H[Contaminated sharp]
H --> I[Sharps container at the point of use]Infection-Control Context Without Turning the Outbreak Into a Mechanism Claim
CDC’s Preventing Unsafe Injection Practices page treats one-time use of needles and syringes as a basic safe-injection practice and states never to reuse a needle or syringe on more than one patient. Unsafe injection practices have been associated with spread of viruses, bacteria, and fungi. FDA’s consumer update separately tells patients to choose a health care provider specially trained in microneedling and to discuss infection risk if tools are not cleaned or used properly. That sentence can be misread as authorizing needle reuse; the classification and 510(k) record locate cleaning on reusable components and sterility on the sealed cartridge or tip.
The seriousness of poor infection control in cosmetic needling-plus-injection services is documented in CDC’s MMWR investigation of presumptive HIV transmission associated with platelet-rich plasma microneedling facials at a New Mexico spa, 2018–2023 (73(16);372–376, 25 April 2024). Investigators identified four former spa clients and one sexual partner of a spa client with highly similar HIV strains. All four women had received PRP with microneedling at the unlicensed spa; the man had not received spa services. The report describes this as HIV transmission through cosmetic injection services via contaminated blood that had not been previously documented. Nucleotide sequence analysis linked the cluster. The exact contamination source remains unknown.
On-site inspection findings in that MMWR include a centrifuge and unlabeled tubes of blood on a kitchen counter; unlabeled tubes of blood and medical injectables stored in a kitchen refrigerator with food; unwrapped syringes in drawers, on counters, and in regular trash; no autoclave found on the premises; and disposable electric desiccator tips cleaned by alcohol immersion and reused. Those facts support taking sterility questions seriously. They do not prove that a reused mechanical QAI cartridge was the transmission vehicle, and they do not describe a licensed dermatology clinic following a labeled SkinPen or Exceed IFU.
FDA lists infection among less common microneedling risks and lists bleeding, bruising, redness, and pigment change among more typical local effects. This page does not estimate how often informal cartridge reuse occurs, does not invent decontamination-failure percentages, and does not map Fitzpatrick skin type to infection probability. Device-malfunction and energy-injury reports belong in microneedling MAUDE adverse-event reviews and the RF microneedling adverse-event workflow, not in a sterility checklist.
A Practical Observation List Patients Can Use in the Room
You do not need to handle needles, photograph cartridges, or inspect a sharps bin. Observation is visual and verbal. State rules on who may perform microneedling and whether a patient can demand a specific demonstration vary; there is no single national “right to watch a pouch being opened.” A licensed practice that follows labeled IFUs should still be able to answer a calm question about a new sterile pack for this visit.
| What you can observe | Reassuring pattern | Pattern that warrants a question or declining |
|---|---|---|
| Packaging before assembly | Clinician opens an intact, sealed blister or pouch in view, with brand and an unexpired date if those marks are on the pack. | Cartridge already mounted when you enter; loose needles from an unsealed bag; handwritten name on used packaging. |
| Single-use / sterile markings | Manufacturer sterile symbol and “do not reuse” type marking are common on medical packs. SkinPen’s DEN160029 lock-out is a device feature that refuses a used cartridge; not every pen has that lock. | No manufacturer labeling; expired date; generic unbranded pack on a brand-name console. |
| Handle barrier versus tip | If the IFU uses a sheath (SkinPen BioSheath is a named example), a new cover goes on the reusable body before the sterile cartridge. RF tips are a different accessory: look for a new pin array, not a handle sleeve that “makes the pins sterile.” | Staff describe wiping or autoclaving the cartridge or pins themselves as the sterility step. |
| Name match | Cartridge or tip brand matches the booked platform (SkinPen cartridge on a SkinPen; Morpheus8 tip on an InMode applicator). | Unbranded or marketplace tips on a brand console. Gray-market authenticity is a separate problem from reuse; clearance of a console is not clearance of a knock-off tip. |
| End of the session | Used cartridge or RF tip goes into a puncture-resistant sharps container at the point of use. | Wiping the cartridge, parking it in a drawer, or offering to save it for a later visit. |
A usable question, without handling equipment: “Could you open a sealed cartridge or tip for this visit so I can see the pack?” If the answer is that cartridges are routinely resterilized, that a used tip is being saved for you, or that a new pack requires an unexpected surcharge that was not disclosed, declining the procedure is a reasonable safety choice. Asking for the device name and lot if offered is consistent with how medical packs are labeled; it is not a license to pocket used needles.
What This Page Does Not Decide
A new sterile cartridge prevents one class of problem: using a labeled single-use sharp that has already contacted another person or another visit. It does not decide candidacy, depth, energy, or aesthetic outcome.
Clearance versus this office. An FDA-cleared console is not proof of sterile technique on a given day. “FDA registered” and CE marks are not clearance. How to read a 510(k) without treating the marketing wrapper as the IFU is in how aesthetic devices get FDA 510(k) clearance.
RF energy injuries. The 15 October 2025 FDA safety communication reports burns, scarring, fat loss, disfigurement, and nerve damage, and the need for surgical repair or medical intervention after some RF microneedling uses. Those are energy and depth injuries, not cartridge-sterility findings. Patient-facing detail is in the RF microneedling FDA warning article.
Skin of color. This article does not generalize pigment or PIH outcomes by Fitzpatrick type. Hygiene boundaries are the same QAI/GEI labeling problem regardless of skin tone; energy and pigment risk are a different evidence base.
Who should operate the device. FDA’s consumer update recommends a health care provider specially trained in microneedling. The RF communication tells patients to seek a licensed clinician experienced with the specific device. This page does not rank clinics or invent a board-certification requirement beyond those statements.
Home reuse. FDA has not authorized microneedling medical devices for OTC sale. This page does not provide cartridge-disinfection instructions, dosing, or a “how to reuse safely” method.
Sources
Primary FDA classification and 510(k) or De Novo summaries, FDA consumer and SUD-reprocessing pages, CDC injection-safety and MMWR outbreak reporting, and OSHA’s bloodborne-pathogens standard:
U.S. Food and Drug Administration. Product Classification: powered microneedle device (QAI). Physical state (single-use cartridge, multi-use motorized base) and technical method (puncture to pinpoint bleeding).
21 CFR 878.4430 Microneedling device for aesthetic use. Class II special controls for sterility, shelf-life packaging, fluid-ingress protection, validated reusable-component reprocessing, and the transdermal-delivery exclusion.
FDA De Novo decision summary: SkinPen Precision System (DEN160029). Sterile disposable cartridge, EO SAL 10^-6, BioSheath, lock-out, and “not to be resterilized or reused.”
FDA 510(k) summary: SkinPen Precision System (K202243). Reusable handpiece plus sterile cartridge; BioSheath remains a nonsterile disposable cover.
FDA 510(k) summary: Exceed microneedling device (K182407). Safety needle cartridge “is sterile and for single use only.”
FDA 510(k) summary: VIVACE electrosurgical system (K193070). Disposable cartridge supplied sterile, single-patient use only, cannot be re-sterilized; generator and handpiece are not disposable.
FDA 510(k) summary: InMode System with Morpheus8 (Fractora) applicators (K192695). Disposable single-use fractional RF tip, gamma sterilized; comparison note on an older non-sterile Fractora tip.
FDA 510(k) summary: InMode RF Pro System (K210492). Tips gamma-sterilized; handle reprocessed per user manual; tips for single use.
FDA. Microneedling Devices: Getting to the Point on Benefits, Risks and Safety. Trained clinician, infection if tools are not cleaned or used properly, no OTC medical-device authorization, RF as a different mechanism, no clearance with PRP or other products. Content current as of 15 October 2025.
FDA. Reprocessing Single-Use Medical Devices: Information for Health Care Facilities. SUD definition; reprocessors regulated as manufacturers; required “Reprocessed device for single use” labeling. Current as of 1 August 2024.
CDC. Preventing Unsafe Injection Practices. One-time use of needles and syringes; never reuse a needle on more than one patient; single-dose containers not retained for later use even on the same patient; limited same-procedure incremental-dosing exception.
OSHA. 29 CFR 1910.1030 Bloodborne pathogens. Contaminated sharps; recapping/shearing prohibitions; point-of-use sharps containers.
FDA Safety Communication. Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling (15 October 2025). Scope boundary for energy injuries, not cartridge sterility.
